Pneumococcal conjugate second or third-dose vaccines (PCVc) in Georgia
Georgia: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 77.0% in 2025. ◆ Volatile
Latest (2025)
77.0%
Change on year
down 6.1%
World rank
124th
of 194 countries
All-time high
86.0%
in 2023
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Georgia, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Georgia recorded 77.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) in 2025.
Compared with earlier readings it is down 6.1% on the previous year and up 381.2% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Georgia peaked at 86.0% in 2023 and was at its lowest, 0.0%, in 2008.
Georgia ranks 124th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Georgia, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 16.0% | — |
| 2016 | 75.0% | +368.8% |
| 2017 | 80.0% | +6.7% |
| 2018 | 81.0% | +1.2% |
| 2019 | 84.0% | +3.7% |
| 2020 | 82.0% | -2.4% |
| 2021 | 82.0% | +0.0% |
| 2022 | 79.0% | -3.7% |
| 2023 | 86.0% | +8.9% |
| 2024 | 82.0% | -4.7% |
| 2025 | 77.0% | -6.1% |
Georgia compared with similar countries
- Georgia's 77.0% is above the median for upper middle income countries, which is 76.0%, 1.0× the median. (57 countries reporting)
- Georgia's 77.0% is below the median for Europe & Central Asia, which is 87.0%, 89% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 33.6% | 0.0% | 84.0% | 10 |
| 2020s | 81.3% | 77.0% | 86.0% | 6 |
Countries ranked near Georgia
More health data for Georgia
- Un projection of annual infant deaths, annual growth rate -3.7 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0382 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,310 deaths per 1,000 people (2090)
- Number of infants who die before age 1 26 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.2207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.2812 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Georgia?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Georgia was 77.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Georgia?
- The highest recorded value was 86.0% in 2023.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Georgia?
- The lowest recorded value was 0.0% in 2008.
- How does Georgia rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Georgia ranks 124th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Georgia?
- Over the last ten years it is up 381.2%. The long-run trend across the full record is volatile.
- Where does this Georgia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).